🟢 Advanced Biomed is trading 13.79% up in pre-market as XBI gains 2.61%

Advanced Biomed is trading at $7.26, up 13.79%, with broader biotech strength offering the most plausible explanation.

• Shares rose from the September 22 close of $6.38.
• No reliable company-specific announcement, earnings release, filing, or analyst action was identified for September 23, 2026.
• XBI was up 2.61% pre-market; trading remains speculative given the company’s small capitalization and limited volume.